Role of the bradykinin B2 receptor in a rat model of local heart irradiation

References

• Bae SW, Kim HS, Cha YN, Park YS, Jo AS, Jo I. 2003. Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signaling pathway. Biochem Biophys Res Commun 306:981–987.
   PubMed Web of Science ®Google Scholar
• Bao G, Gohlke P, Qadri F, Unger T. 1992. Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension 20:74–79.
   PubMed Web of Science ®Google Scholar
• Bell RM, Yellon DM. 2002. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: The role of PI3K, Akt, and eNOS. J Molec Cell Cardiol 35:185–193.
   Web of Science ®Google Scholar
• Binetruy B, Smeal T, Karin M. 1991. Ha-ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 351:122–127.
   PubMed Web of Science ®Google Scholar
• Böckmann S, Paegelow I. 2000. Kinins and kinin receptors: Importance for the activation of leukocytes. J Leukoc Biol 68:587–592.
   PubMed Web of Science ®Google Scholar
• Boerma M, Zurcher C, Esveldt I, Schutte-Bart CI, Wondergem J. 2004. Histopathology of ventricles, coronary arteries and mast cell accumulation in transverse and longitudinal sections of the rat heart after irradiation. Oncol Rep 12:213–219.
   PubMed Web of Science ®Google Scholar
• Boerma M, Roberto KA, Hauer-Jensen M. 2008. Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol. Int J Radiat Oncol Biol Phys 72:170–177.
   PubMed Web of Science ®Google Scholar
• Böhm M, Baumhäkel M, Mahfoud F, Werner C. 2010. From evidence to rationale: Cardiovascular protection by angiotensin II receptor blockers compared with angiotensin-converting enzyme inhibitors. Cardiology 117:163–173.
   PubMed Web of Science ®Google Scholar
• Bohmann D, Bos TJ, Admon A, Nishimura T, Vogt PK, Tijan R. 1987. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238:1386–1392.
   PubMed Web of Science ®Google Scholar
• Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W. 2007. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol 119:1497–1503.
   PubMed Web of Science ®Google Scholar
• Cockcroft JR, Chowienczyk PJ, Brett SE, Bender N, Ritter JM. 1994. Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist. Br J Clin Pharmacol 38:317–321.
   PubMed Web of Science ®Google Scholar
• Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, Peto R, Baum M, Fisher B, Host H. 1994. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12:447–453.
   PubMed Web of Science ®Google Scholar
• Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, Mabuchi K, Marks LB, Mettler FA, Pierce LJ, Trott KR, Yeh ETH, Shore RE. 2010. Radiation-related heart disease: Current knowledge and future prospects. Int J Radiat Oncol Biol Phys 76:656–665.
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A. 2014. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64:252–271.
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). 2011. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 378:1707–1716.
   PubMed Web of Science ®Google Scholar
• Damas J. 1996. The brown Norway rats and the kinin system. Peptides 17:859–872.
   PubMed Web of Science ®Google Scholar
• Das A, Salloum FN, Xi L, Rao YJ, Kukreja RC. 2009. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol 296:H1236–1243.
   PubMed Web of Science ®Google Scholar
• Demirci S, Nam J, Hubbs JL, Nguyen T, Marks LB. 2009. Radiation-induced cardiac toxicity after therapy for breast cancer: Interaction between treatment era and follow-up duration. Int J Radiat Oncol Biol Phys 73:980–987.
   PubMed Web of Science ®Google Scholar
• Fulton D, Gratton J-P, McCabe TJ, Fontana J, Fujio Y, Franke T, et al. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597–601.
   PubMed Web of Science ®Google Scholar
• Fuster V, Voûte J. 2005. MDGs: Chronic diseases are not on the agenda. Lancet 366:1512–1514.
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Kapoor JR. 2009. Radiation induced heart disease: Systemic disorders in heart disease. Heart 95:252–958.
   PubMed Web of Science ®Google Scholar
• Imamura T, Dubin A, Moore W, Tanaka Rm Travis J. 1996. Induction of vascular permeability enhancement by human tryptase: Dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab Invest 74:861–870.
   PubMed Web of Science ®Google Scholar
• Jaworski C, Mariani JA, Wheeler G, Kaye DM. 2013. Cardiac complications of thoracic irradiation. J Am Coll Cardiol 61:2319–2328.
   PubMed Web of Science ®Google Scholar
• Jones SP, Bolli R. 2006. The ubiquitous role of nitric oxide in cardioprotection. J Molec Cell Cardiol 40:16–23.
   PubMed Web of Science ®Google Scholar
• Keefe DL. 2003. Trastuzumab-associated cardiotoxicity. First published: Cancer 2002;95:1592–1600. Erratum: Cancer 2003;97:1136.
   Google Scholar
• Kim NN, Villegas S, Summerour SR, Villarreal FJ. 1999. Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide. J Mol Cell Cardiol 31:456–466.
   Google Scholar
• Larsen RL, Jakacki RI, Vetter VL, Meadows AT, Silber JH, Barber G. 1992. Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults. Am J Cardiol 70:73–77.
   PubMed Web of Science ®Google Scholar
• Leppä S, Saffrich R, Ansorge W, Bohmann D. 1998. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J 17:4404–4413.
   PubMed Web of Science ®Google Scholar
• Marceau F, Bachvarov DR. 1998. Kinin receptors. Clin Rev Allergy Immunol 16:385–401.
   PubMed Web of Science ®Google Scholar
• Marceau F, Lussier A, Regoli D, Giroud JP. 1983. Pharmacology of kinins: Their relevance to tissue injury and inflammation. Gen Pharmacol 14:209–229.
   PubMedGoogle Scholar
• Martinez FO, Gordon S. 2014. The M1 and M2 paradigm of macrophage activation:Time for reassessment. F1000Prime Rep 6:13.
   Google Scholar
• Mount PF, Kemp BE, Power DA. 2007. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 42:271–279.
   PubMed Web of Science ®Google Scholar
• Nellessen U, Zingel M, Hecker H, Bahnsen J, Borschke D. 2010. Effects of radiation therapy on myocardial cell integrity and pump function: Which role for cardiac biomarkers? Chemother 56:147–152.
   PubMed Web of Science ®Google Scholar
• Regoli D, Plante GE, Gobeil F. 2012. Impact of kinins in the treatment of cardiovascular diseases. Pharmacol Ther 135:94–111.
   PubMed Web of Science ®Google Scholar
• Rose BA, Force T, Wang Y. 2010. Mitogen-activated protein kinase signaling in the heart: Angels versus demons in a heart-breaking tale. Physiol Rev 90:1507–1546.
   PubMed Web of Science ®Google Scholar
• Sridharan V, Sharma SK, Moros EG, Corry PM, Tripathi P, Lieblong BJ, Guha C, Hauer-Jensen M, Boerma M. 2013. Effects of radiation on the epidermal growth factor receptor pathway in the heart. Int J Radiat Biol 89:539–547.
   PubMed Web of Science ®Google Scholar
• Sridharan V, Tripathi P, Sharma SK, Moros EG, Corry PM, Lieblong BJ, Kaschina E, Unger T, Thöne-Reineke C, Hauer-Jensen M, Boerma M. 2012. Cardiac inflammation after local irradiation is influenced by the kallikrein-kinin system. Cancer Res 72:4984–4992.
   PubMed Web of Science ®Google Scholar
• Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, Miyazaki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, Shibasaki Y, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Takahashi H, Iwasaka T. 1999. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 104:925–935.
   PubMed Web of Science ®Google Scholar
• Wang X, Wei M, Kyykasjärvi P, Laurikka J, Rinne T, Moilanen E, Tarkka M. 2009. The anti-inflammatory effect of bradykinin preconditioning in coronary artery bypass grafting (bradykinin and preconditioning). Scand Cardiovasc J 43:72–79.
   PubMed Web of Science ®Google Scholar
• Wethal T, Lund MB, Edvardsen T, Fosså SD, Pripp AH, Holte H, Kjekshus J, Fosså A. 2009. Valvular dysfunction and left ventricular changes in Hodkin's lymphoma survivors: A longitudinal study. Br J Cancer 101:575–581.
   PubMed Web of Science ®Google Scholar
• Windak R, Müller J, Felley A, Akhmedov, Wagner E, Pedrazzini T, Sumara G, Ricci R. 2013. The AP-1 transcription factor c-Jun prevents stress-imposed maladaptive remodeling of the heart. PLoS One 8:e73294.
   PubMedGoogle Scholar
• Wirth K, Hock FJ, Albus U, Linz W, Alpermann HG, Anagnostopoulos H, Henke St, Breipohl G, König W, Knolle J, Schölkens BA. 1991. Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol 102:774–777.
   PubMed Web of Science ®Google Scholar
• Wonnacott S. 1990. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 11:216–219.
   PubMed Web of Science ®Google Scholar
• Xu J, Carretero OA, Zhu L, Shesely EG, Rhaleb N, Dai X, Wang L, Yang JJ, Yang X. 2013. Protective role of AT2 and B1 receptors in kinin B2-receptor-knockout mice with myocardial infarction. Clin Sci 124:87–96.
   PubMed Web of Science ®Google Scholar